Heterogeneity of behavioural profile between three new putative selective D3 dopamine receptor antagonists using an ethologically based approach

被引:55
作者
Clifford, JJ [1 ]
Waddington, JL [1 ]
机构
[1] Royal Coll Surg Ireland, Dept Clin Pharmacol, Dublin 2, Ireland
关键词
D-3 dopamine receptor; D-3; antagonist; GR; 103691; nafadotride; U99194A; spontaneous behaviour; ethological assessment;
D O I
10.1007/s002130050567
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects on behaviour of the putative selective D-3 dopamine receptor antagonists GR 103691, nafadotride and U 99194A were compared with those of the generic D-2-like antagonist haloperidol using an ethologically based approach. Neither GR 103691 (0.008-1.0 mg/kg) nor nafadotride (0.025-1.6 mg/kg) influenced any element of behaviour. Conversely, U99194A (1.67-45 mg/kg) effected a dose-dependent stimulation of episodes of non-stereotyped sniffing, , locomotion, chewing and eating, with some stimulation of rearing, and reduced baseline levels of grooming; thereafter, as sniffing and locomotion declined, stimulation of episodes of grooming emerged. Haloperidol (0.0008-0.1 mg/kg) failed to promote any element of behaviour and reduced baseline levels of grooming; responsivity to U99194A was antagonised by pretreatment with haloperidol. The lack of effect of GR 103691 (>100-fold D-3/D-2 selectivity) and nafadotride (10-fold D-3/D-2 preference), in contrast to the characteristic "ethogram" for U99194A (25-fold D-3/D-2 selectivity), indicated a fundamental difference in their mechanisms of action. This topography of responsivity to U99194A overlapped somewhat with the profiles of both D-2-like and D-1-like agonists, and its sensitivity to antagonism by haloperidol also indicated a dopaminergic basis thereto. However, differences among GR 103691, nafadotride and U99194A bore no relation to their relative selectivities for the D-3 receptor. and the basis thereof remains unclear. Theorising as to the behavioural role of the D-3 receptor may need to be tempered pending the identification of a range of chemically distinct D-3 antagonists of higher selectivity.
引用
收藏
页码:284 / 290
页数:7
相关论文
共 43 条
[1]   Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D-2 receptor antagonist L-741,626 [J].
Bowery, BJ ;
Razzaque, Z ;
Emms, F ;
Patel, S ;
Freedman, S ;
Bristow, L ;
Kulagowski, J ;
Seabrook, GR .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (07) :1491-1497
[2]   The behavioural and neurochemical profile of the putative dopamine D-3 receptor agonist, (+)-PD 128907, in the rat [J].
Bristow, LJ ;
Cook, GP ;
Gay, JC ;
Kulagowski, JJ ;
Landon, L ;
Murray, F ;
Saywell, KL ;
Young, L ;
Hutson, PH .
NEUROPHARMACOLOGY, 1996, 35 (03) :285-294
[3]   LACK OF DISCRIMINATION BY AGONISTS FOR D-2 AND D-3 DOPAMINE-RECEPTORS [J].
BURRIS, KD ;
PACHECO, MA ;
FILTZ, TM ;
KUNG, MP ;
KUNG, HF ;
MOLINOFF, PB .
NEUROPSYCHOPHARMACOLOGY, 1995, 12 (04) :335-345
[4]   BEHAVIORAL-EFFECTS OF THE PUTATIVE D-3 DOPAMINE RECEPTOR AGONIST 7-OH-DPAT IN RELATION TO OTHER D-2-LIKE AGONISTS [J].
DALY, SA ;
WADDINGTON, JL .
NEUROPHARMACOLOGY, 1993, 32 (05) :509-510
[5]   BEHAVIORAL EVIDENCE FOR D-1-LIKE DOPAMINE-RECEPTOR SUBTYPES IN RAT-BRAIN USING THE NEW ISOCHROMAN AGONIST A-68930 AND ISOQUINOLINE ANTAGONIST BW-737C [J].
DALY, SA ;
WADDINGTON, JL .
PSYCHOPHARMACOLOGY, 1993, 113 (01) :45-50
[6]   PHARMACOLOGICAL ASPECTS OF R-(+)-7-OH-DPAT, A PUTATIVE DOPAMINE D-3 RECEPTOR-LIGAND [J].
DAMSMA, G ;
BOTTEMA, T ;
WESTERINK, BHC ;
TEPPER, PG ;
DIJKSTRA, D ;
PUGSLEY, TA ;
MACKENZIE, RG ;
HEFFNER, TG ;
WIKSTROM, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 249 (03) :R9-R10
[7]   Behavioural effects in the rat of the putative dopamine D-3 receptor agonist 7-OH-DPAT: Comparison with quinpirole and apomorphine [J].
Depoortere, R ;
Perrault, G ;
Sanger, DJ .
PSYCHOPHARMACOLOGY, 1996, 124 (03) :231-240
[8]   Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective ''D-1 like'' dopamine receptor agonist A 68930 and selective ''D-2-like'' agonist RU 24213 [J].
Deveney, AM ;
Waddington, JL .
PSYCHOPHARMACOLOGY, 1996, 124 (1-2) :40-49
[9]   Psychopharmacological distinction between novel full-efficacy ''D-1-like'' dopamine receptor agonists [J].
Deveney, AM ;
Waddington, JL .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 58 (02) :551-558
[10]   PHARMACOLOGICAL CHARACTERIZATION OF BEHAVIORAL-RESPONSES TO SK-AND-F-83959 IN RELATION TO D-1-LIKE DOPAMINE-RECEPTORS NOT LINKED TO ADENYLYL-CYCLASE [J].
DEVENEY, AM ;
WADDINGTON, JL .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (03) :2120-2126